89Bio Inc (ETNB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ETNB | AZN | AMGN | GILD | BMY |
| Company | 89Bio Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 14.83 | 205.64 | 388.00 | 147.87 | 62.37 |
| High | 14.87 | 206.30 | 391.29 | 150.77 | 62.89 |
| Low | 14.82 | 203.34 | 381.89 | 147.80 | 61.98 |
| Latest | 14.84 | 203.73 | 385.70 | 150.03 | 62.34 |
| Change | unch | -4.72 | -2.46 | +1.08 | -0.03 |
| % Change | unch | -2.26% | -0.63% | +0.73% | -0.05% |
| Volume | 55,645,300 | 1,718,800 | 2,838,100 | 7,183,200 | 17,627,500 |
| 20-Day Average Volume | 6,202,360 | 2,509,735 | 3,036,650 | 7,877,460 | 14,046,479 |
| Previous Close | 14.84 | 208.45 | 388.16 | 148.95 | 62.37 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 14.81 | 200.05 | 372.36 | 149.68 | 60.21 |
| 20-Day Raw Stochastic | 54.05% | 69.12% | 89.39% | 57.99% | 93.11% |
| 20-Day Relative Strength | 74.10 | 57.91 | 63.97 | 59.52 | 67.26 |
| Weighted Alpha | +10.94 | +40.10 | +30.38 | +38.44 | +17.51 |
| Today's Opinion | 100% Buy | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Previous Opinion | 100% Buy | 100% Buy | 100% Buy | 88% Buy | 100% Buy |
| Last Month's Opinion | 100% Buy | 88% Buy | 100% Buy | 100% Buy | 80% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.27% since 10/22/25 | -0.59% since 02/23/26 | +1.66% since 02/23/26 | +0.13% since 02/23/26 | +1.78% since 02/23/26 |
| Low | 14.78 on 10/24/25 | 202.64 on 02/26/26 | 374.25 on 02/26/26 | 143.09 on 02/26/26 | 60.65 on 02/26/26 |
| High | 14.87 on 10/29/25 | 209.93 on 02/27/26 | 391.29 on 03/02/26 | 150.77 on 03/02/26 | 62.89 on 03/02/26 |
| 1-Month | |||||
| %Chg | +0.95% since 09/29/25 | +8.13% since 02/02/26 | +11.90% since 02/02/26 | +5.00% since 02/02/26 | +11.54% since 02/02/26 |
| Low | 14.67 on 09/30/25 | 183.63 on 02/03/26 | 338.59 on 02/03/26 | 142.03 on 02/03/26 | 55.49 on 02/03/26 |
| High | 14.93 on 10/02/25 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 3-Month | |||||
| %Chg | +60.95% since 07/29/25 | +12.97% since 12/02/25 | +13.99% since 12/02/25 | +21.08% since 12/02/25 | +29.20% since 12/02/25 |
| Low | 7.84 on 09/15/25 | 178.08 on 01/21/26 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 49.42 on 12/03/25 |
| High | 15.06 on 09/18/25 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | +96.56% since 04/29/25 | +27.03% since 09/02/25 | +34.43% since 09/02/25 | +33.11% since 09/02/25 | +31.49% since 09/02/25 |
| Low | 7.37 on 05/15/25 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 42.52 on 10/29/25 |
| High | 15.06 on 09/18/25 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,200,891 | 323,286,752 | 209,244,640 | 184,909,664 | 127,014,880 |
| Shares Outstanding, K | 148,308 | 1,550,908 | 539,068 | 1,241,421 | 2,036,474 |
| Annual Sales | 0 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -367,080,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 0 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -111,500,000 | 2,326,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 1.27 | 0.34 | 0.46 | 0.36 | 0.29 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.71 on 08/07/25 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 11/06/25 | 05/05/26 | 05/07/26 | 04/23/26 | 04/23/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.790 on 12/15/25 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 02/13/26 | 03/13/26 | 01/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 25.73 | 17.76 | 18.28 | 10.14 |